/PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes…Read More
Innovent Released 2024 ESG Report, Underscoring Commitment to Sustainable Development and Global Innovation
Related Posts
Add A Comment
